Adds potential first-in-class,N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads Strengthens the Novartis ...

Researchers at the University of Bayreuth and Forschungszentrum Jülich have demonstrated that specific light-sensitive ...

U.S. startups announced sizable funding rounds at a steady clip during a truncated holiday week, with energy and AI leading the way. Houston-based energy startup Joulent secured the biggest round, a ...

USA News Group, There is a growing consensus in artificial intelligence that the models themselves are becoming interchangeable, and that ...

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian ...

Anthropic AI for Science event livestreams today as the company pitches Claude to pharma and biotech leaders. The session ...

Over the past several years, we have seen accelerating technological change. Machine learning is accelerating drug discovery, ...

Ligand Pharma (LGND) stock jumped in the final week of June, but the proximate cause was the pricing of $625M of convertible ...

IND authorization paves the way for initiation of GT-02287 Phase 2 clinical development in the U.S., expected during 3Q26 FDA's decision follows positive Phase 1 results for GT-02287 in both healthy ...

This webinar explores how pharma and biotech companies can adopt scalable 3D high content analysis (HCA) to accelerate drug ...

Oversubscribed $225 million concurrent private investment in public equity ("PIPE") with available cash to the combined ...

This statistical finding supports a lower liver-weight signal after adjustment for body fat percentage, suggesting the finding was not fully explained by measured body fat in this modelLiver-weight ...